İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2022

Serum adiponectin levels and adiponectin +276 G/T gene polymorphism in newborns with large and small birth weights

The Journal of Maternal-Fetal & Neonatal Medicine

YÖKSİS OpenAlex SJR Q2 JCR Q4 Atıf 1 Yüzdelik 49.6% FWCI 0.15
Yıl
2022
ISSN
1476-7058
Tür
article

Veri kaynağı ayrımı

  • YÖKSİS YÖKSİS makale kaydı
  • OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

İngilizce (OpenAlex)

Purpose Adiponectin may be an important indicator in the regulation of fetal and neonatal growth due to its metabolism, energy balance, and insulin-sensitizing action. The current study’s goal was to determine if there is a link between adiponectin +276 G/T gene polymorphism and serum adiponectin level in newborns classified as appropriate for gestational age (AGA), small for gestational age (SGA), or large for gestational age (LGA).Methods The study included newborns classified as AGA (n = 65), SGA (n = 65), or LGA (n = 65) according to their gestational age or birth weight. To determine the presence of adiponectin +276 G/T gene polymorphism, genotyping was done using polymerase chain reaction-restriction fragment length polymorphism. Enzyme-linked immunosorbent assay was used to determine the level of adiponectin in the blood.Results The SGA newborns had significantly lower levels of serum adiponectin than the AGA and LGA newborns. There were statistically significant differences between the genotype frequencies (GG, GT, TT) of the SGA newborns (29.9%, 45.1%, 13.9%), the AGA newborns (41.6%, 20.7%, 44.4%), and the LGA newborns (28.6%, 34.1%, 41.7%) (chi-square = 15.8; degree of freedom = 4; p = .003). The newborns carrying the GT genotype had an increased risk of being SGA compared to those carrying the GG and TT genotypes (odds ratio [OR] = 3.07; confidence interval [CI] = 95% (1.38–6.64); p = .005 and OR = 6.96; CI = 95% (2.19–22.1); p < .001, respectively). The newborns carrying the GG and TT genotypes had better protection against being SGA than those carrying the GT genotype (OR = 0.33; CI = 95% (0.15–0.72); p = .005 and OR = 0.14; CI = 95% (0.05–0.46); p < .001, respectively). The newborns carrying the GT genotype had lower birth weights, head circumferences, and ponderal indices than those carrying the TT genotype (p < .001). The serum adiponectin levels between adiponectin +276 G/T genotypes did not differ significantly (p = .429). In addition, serum adiponectin level showed a significant positive correlation with birth weight, birth length, head circumference, and ponderal index in all newborns.Conclusion The results of the current study suggest that the adiponectin +276 G/T gene polymorphism was associated with an increased chance of being born SGA or LGA. The effect of this polymorphism on newborn birth size was independently associated with serum adiponectin levels. Adiponectin may play a role in fetal growth.

Konular

  • Adipokines, Inflammation, and Metabolic Diseases
  • Birth, Development, and Health
  • Gestational Diabetes Research and Management

Birincil konu Adipokines, Inflammation, and Metabolic Diseases

Yazarlar

  1. EMİNE ESİN YALINBAŞ
  2. RAZİYE AKCILAR KÜTAHYA SAĞLIK BİLİMLERİ ÜNİVERSİTESİ